Misoprostol (Cytotec) at 20 Weeks Gestation: Risks, Contraindications, and Safe Alternatives

Misoprostol (brand name Cytotec) is contraindicated for pregnancy termination at 20 weeks gestation or beyond. At this stage, the medication is ineffective for complete expulsion and carries unacceptably high risks of severe hemorrhage, uterine rupture, cervical laceration, infection, and retained products requiring surgical intervention.

Pharmacology & Approved Uses

• FDA-approved: Prevention of NSAID-induced gastric ulcers.
• Off-label obstetric uses: Cervical ripening before labor induction, management of postpartum hemorrhage, first-trimester medical abortion (with mifepristone) up to 10–12 weeks.

Why 20 Weeks Is a Critical Threshold

• Fetal size and placental attachment make complete medical evacuation unlikely.
• Uterine musculature is highly sensitive to prostaglandin-induced hyperstimulation, increasing rupture risk—especially with prior uterine surgery.
• Coagulopathy risk rises with prolonged bleeding and retained tissue.

Safe, Evidence-Based Alternatives for Second-Trimester Termination

Clinical Imperative

Any patient considering termination at or beyond 20 weeks must be evaluated by a qualified obstetric provider. Management should occur in a facility equipped for surgical backup, blood transfusion, and intensive care. Self-administration of misoprostol at this gestation is dangerous and illegal in many jurisdictions.